Nordea Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,636
Closed -$1.88M 1067
2017
Q2
$1.88M Buy
16,636
+3,436
+26% +$384K ﹤0.01% 658
2017
Q1
$1.32M Buy
13,200
+1,768
+15% +$189K ﹤0.01% 741
2016
Q4
$1.23M Buy
11,432
+1,249
+12% +$146K ﹤0.01% 672
2016
Q3
$1.27M Buy
10,183
+383
+4% +$45.2K ﹤0.01% 568
2016
Q2
$1.04M Hold
9,800
﹤0.01% 535
2016
Q1
$1.12M Buy
9,800
+2,400
+32% +$282K ﹤0.01% 525
2015
Q4
$1.05M Sell
7,400
-4,600
-38% -$531K ﹤0.01% 530
2015
Q3
$1.08M Sell
12,000
-300
-2% -$31.7K ﹤0.01% 437
2015
Q2
$1.42M Sell
12,300
-400
-3% -$42K 0.01% 390
2015
Q1
$1.21M Buy
+12,700
New +$950K ﹤0.01% 424

Other funds holding CBPO

Nordea Investment Management's CBPO Position: Q3 2017 in Review

Nordea Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 16,636 shares — an estimated $1.88M sold.

Nordea Investment Management first reported a position in CBPO in Q1 2015 and held it in 10 quarters. The position peaked at $1.88M in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Nordea Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Nordea Investment Management sold 16,636 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $1.88M.
  • Nordea Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 10 quarters.
  • Nordea Investment Management's China Biologic Products Holdings, Inc. position peaked at $1.88M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Nordea Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.